General Session

(E2) General Session: Current State of Knowledge: Infusate Compatibility, Peripheral vs Central

General Session Speaker(s)

• 

  Marc Stranz, PharmD

  Partner
  StranzCrossley Inc

  BD/BARD: Member of committee supporting Marcia Ryder's research on phlebitis in sheep (Status: Ongoing), Other Financial or Material Support (Status: Ongoing)

Drug-induced vascular damage is a relatively common event that lacks substantial and reproducible population causality information. For decades the only data was from animals, which does not directly correlate to human injury. In recent years human data on endothelial damage has become available, but failure to control for a number of variables has prevented data aggregation and validation of trends. This review looks at the current information and draws what conclusions can be supported.

Learning Objectives:

• Review the changes to the 2016 INS Standards of Care regarding infusate appropriateness.
• Understand the risk factors for phlebitis and extravasation.
• Look at what’s been published since 2016.
• Describe practical precautions when administering drugs thought to cause vascular and tissue injury.